The World Health Organisation (WHO) has approved the Covid 19 vaccine developed by China for emergency use. This move will pave the way for the vaccine to be distributed globally.
WHO Gives Green Signal To Sinopharm
As per the latest reports, WHO has given the green light to the Chinese developed Covid 19 vaccine named Sinopharm. It is the sixth vaccine in the world to have received validation from the WHO for safety, efficacy, and quality against the Covid 19 virus.
ALSO READ: WHO Approves Moderna Vaccine For Emergency Use As Covid 19 Cases Continue To Grow
The news was revealed by the WHO Director-General Tedros Ghebreyesus during a webinar on Covid 19. The Sinopharm vaccine is being produced by the Beijing Bio-Institute of Biological Products Co Ltd which is a subsidiary of China National Biotec Group.
The WHO said that the Sinopharm product is an inactivated vaccine called the SARS-CoV-2 vaccine (Vero Cell). It has easy storage requirements which makes it highly suitable in settings where resources are not easily available. The vaccine is already in use in 42 countries in the world.
The European Medicine Agency (EMA), earlier this week started to roll out a review for the second Chinese Covid 19 vaccine called Sinovac. EMA said that the vaccine triggers the production of antibodies that target SARS-CoV-2 and helps in protection against the disease.
Before Sinopharm, WHO has given emergency use for vaccines by Pfizer-BioNTech, Johnson and Johnson, Moderna and AstraZeneca.
US Waives Covid Patent For Better Access
Earlier this week, US President Joe Biden said that they want to play a more active role in helping the world in fighting the Covid 19. US has waived the Covid 19 patent which would allow other countries to manufacture them as well.
ALSO READ: WHO Questions Indian Covid Variant Impact Amidst Worsening Situation
Furthermore, they have decided to give away 60 million doses of Astrazeneca and speed up the production of Johnson and Johnson. The country has already 240 million doses of Covid 19 vaccines and plans to provide for another 500 million vaccines.
